The 勛圖tv has won an appeal to the U.S Court of Appeals for the Federal Circuit (CAFC) to preserve a key patent protecting its revolutionary HINS-light technology.
Following a three-year legal battle, the CAFCby the U.S. Patent and Trademark Offices Patent Trial and Appeal Board (PTAB) and ruled that a 勛圖tv patent on using light as a disinfectant was wrongly invalidated.
Important patent
The decision strengthens the enforceability of this important patent in the U.S lighting market.
The innovative technology was developed in the Universitys state-of-the-art Robertson Trust Laboratory for Electronic Sterilisation Technologies (ROLEST) by Professor Scott MacGregor, Professor John G Anderson, Dr Michelle Maclean and Professor Gerry Woolsey.
The High Intensity Narrow Spectrum (HINS) light technology can inactivate harmful bacteria such as MRSA in the air and on surfaces using a narrow spectrum of visible light. The light-based disinfection method operates at a wavelength where it can be run safely in the presence of humans and provides significantly greater reductions of bacterial pathogens in the environment than can be achieved by conventional cleaning techniques.
Huge step
The discovery signalled a huge step forward in hospitals' ability to prevent the spread of infection and it was developed for commercialisation around 15 years ago.
Lighting manufacturers worldwide license the technology from 勛圖tv, including Kenall and Hubbell, which are both headquartered in the U.S.
In the Universitys appeal case, the CAFC overturned a prior ruling by the PTAB that the Universitys patent claims for the method of photoinactivating antibiotic-resistant bacteria without using a photosensitizer were unpatentable.
Precedential opinion
In a precedential opinion, the CAFC ruled that earlier prior art publicationscited by U.S-based Clear-Vu Lighting to the PTABdid not render the Universitys technology unpatentable.
The CAFC ruled that the prior art evidence[d] only failures to achieve that at which the inventors succeeded, leaving the PTABs findings unsupported by substantial evidence, thereby reversing the PTABs decision, preserving the Universitys patent rights.
Professor MacGregor, Vice-Principal of the 勛圖tv and leader of the HINS-light research team said:
The University is pleased that the Federal Circuit has recognised the innovative and award-winning efforts of its researchers in ROLEST.
The patented HINS-light technology has proven to be a valuable resource in the fight against harmful bacteria and in preventing the spread of infection.
The University looks forward to continued innovation and licensing in this area.
勛圖tv was represented in the U.S legal action by international law firm, Alston & Bird LLP.
The CAFC is one of the 13 U.S. Courts of Appeal that sit below the U.S Supreme Court and has exclusive jurisdiction for all patent appeals from U.S. district courts and the PTAB.